Rosva Pharm - Russian pharmaceutical company
Manufacture of medicines and active pharmaceutical substances according to GMP standards
LLC Rosva Pharm is a subsidiary of JSC Biotech Rosva, founded in 2011
2018
2020
2021
2022
2023
2024
The biotechnical complex is put into operation
The Rosva Pharm production site for the production of active pharmaceutical substances has been established on the basis of the existing complex. Construction of a "plant for the production of infusion and injectable dosage forms" has begun
Launch of the first line for the production of infusion and injection fluids
Launch of the second and third production lines for the production of infusion and injection fluids
Registration of the first infusion and injection medications
Confirmation of compliance of the production of medicines with the requirements of the EAEU rules of good manufacturing practice
Our mission
To become a leading manufacturer of high-quality medicines based on domestic raw materials.
We strive to ensure the health and well-being of society by combining advanced global technologies and domestic substances.
We implement the most advanced technologies to produce high-quality products that meet international standards.
Production
Rosva Pharm today consists of 3 production lines for the production of infusion and injection medicines, equipped with high-tech equipment with a high level of automation from leading European and global manufacturers that meet all quality and safety standards
of the pharmaceutical industry
We implement the most advanced technologies to produce high-quality products that meet international standards.
Technologies
In 2021, Rosva Pharm expanded its production facilities and established a production site for the production of standard infusion solutions and liquid medicines in ampoules using the BFS method using final sterilization with superheated water.
We implement the most advanced technologies to produce high-quality products that meet international standards.
Quality control
Rosva Pharm has its own microbiological and analytical laboratories, thanks to which quality control of incoming raw materials and finished products is carried out at all stages of production.
We implement the most advanced technologies to produce high-quality products that meet international standards.
Injectable medications
These are sterile medicines intended for injection, infusion, or implantation. In this regard, the quality of injectable drugs is subject to increased requirements: sterility, stability during manufacture and storage, absence of mechanical inclusions, and pyrogenicity.
Rosva Pharm medicines are available in polymer ampoules using BFS technology, which is recognized as the most advanced in the world for the production of sterile medicinal solutions.
Infusion medications
They are used for parenteral therapy in order to replenish and maintain the body's water-electrolyte balance and ensure its optimal metabolism. Infusion therapy is of crucial importance in the treatment of severe patients, and more than 30% of all hospitalized patients receive intravenous solutions, or more than 30 million people per year. The production of infusion solutions by Rosva Pharm combines advanced technologies and strict quality control in accordance with GMP standards.
Active pharmaceutical substances
Medicinal products in the form of one or more active substances with pharmacological activity, regardless of the nature of origin, intended for the production, manufacture of medicinal products and determining their effectiveness. A special feature of Rosva Pharm's API is its own full-cycle production, starting from the production of the API molecule and its further physical processing (purification, drying, etc.)
© Rosva Pharm LLC, 2026
info@rosvapharm.com
Address
Telephone
E-mail
+7(4842)21-00-60
Russia, 248903, Kaluga region, Kaluga, territory “Industrial zone industrial Park “Rosva", building 1